Industry NewsNew data shows that Abbott’s FreeStyle Libre System reduces diabetes-related hospitalizations for people with type 2 diabetes on once-daily insulin therapy
Industry NewsAbbott, CamDiab and Ypsomed unveil new automated insulin delivery partnership for people with diabetes
Product NewsAbbott receives U.S. FDA clearance for new cardiac mapping system to improve how doctors treat abnormal heart rhythms
Industry NewsAbbott introduces NeuroSphere Virtual Clinic, first-of-its-kind remote neuromodulation patient-care technology in the UK
Product NewsAbbott’s Amplatzer Amulet Occluder shown to offer superior left atrial appendage closure for people at risk of stroke
Industry NewsAbbott’s Amplatzer Amulet device approved by FDA to treat people with atrial fibrillation at risk of stroke
Industry NewsAbbott receives FDA clearance for its imaging technology using artificial intelligence for vessels in the heart
Industry NewsAbbott’s XIENCE stent receives FDA approval for shortest blood thinner course for high bleeding risk patients
Industry NewsAbbot receives CE mark for its Panbio rapid Antigen Self-Test, opening access throughout Europe to fast, reliable COVID-19 testing